Nd: YAG Laser in the Treatment of Basal Cell Carcinoma

Efficacy and Safety of Nd: YAG Laser in the Treatment of Basal Cell Carcinoma: A Novel Nonsurgical Approach for Malignant Skin Tumor

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20260418069090N1

Enrollment

Registered

2026-05-05

Start date

2026-04-30

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basal Cell Carcinoma of skin. Basal cell carcinoma of skin, unspecified

Interventions

Intervention 1: Intervention group: Treatment will be performed using an Nd:YAG laser (Dynamis device) equipped with the R33 handpiece, utilizing the following parameters: pulse duration of 25 ms, a s

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 Having at least one BCC lesion

Exclusion criteria

Exclusion criteria: Inability to continue treatment or follow-up Serious treatment-related adverse events Pregnancy Active infection at the lesion site Need for contraindicated medications UV sensitive disorders

Design outcomes

Primary

Measure	Time frame
BCC recurrence 4 weeks. Timepoint: 4 weeks and 3 month later. Method of measurement: Physical examination by dermatologist.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmirhosein naderi

Tehran University of Medical Sciences

naderi.amirh@gmail.com+98 21 5288 8282

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026